EUVIMED · CrossrefJournal
Journal of Liver Cancer
ISSN 2288-8128 · Korean Liver Cancer Association
Latest articles
Elevated serum KIF20A in hepatocellular carcinoma: exploring its potential as a circulating biomarker
Lower recurrence after ablation for MASLD-related versus alcohol-related hepatocellular carcinoma
Stemness plasticity in hepatocellular carcinoma: spatial niches and therapeutic implications
Enhancing non-LR-5 liver lesion diagnoses: the incremental value of serum alpha-fetoprotein and PIVKA-II for detecting hepatocellular carcinoma components
PNPLA3 I148M is unrelated to HCC occurrence but associates with poorer tumor differentiation in Korean MASLD: a prospective cohort of 562 patients
Exploring single-cell and multi-omics technologies and their role in unraveling tumor heterogeneity of hepatocellular carcinoma
Systemic therapy for combined hepatocellular-cholangiocarcinoma: a comprehensive review of chemotherapy, immunotherapy, and targeted therapy
Contemporary overview of liver transplantation for intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma
The role of radiotherapy in the management of combined hepatocellular-cholangiocarcinoma: current evidence and future perspectives
Imaging differentiation of hepatocellular carcinoma, combined hepatocellular-cholangiocarcinoma, and intrahepatic cholangiocarcinoma: pitfalls and advances
Combined hepatocellular-cholangiocarcinoma: a contemporary pathologic and molecular perspective
Expert survey on systemic therapy indications for hepatocellular carcinoma in Korea: bridging clinical practice and reimbursement criteria
Public health strategies for hepatocellular carcinoma: from risk factors to prevention and control
Surgical treatment of hepatocellular carcinoma: an expert consensus-based practical recommendation from the Korean Liver Cancer Association
Molecular and immune landscape of hepatocellular carcinoma for therapeutic development
A concise review of updated global guidelines for the management of hepatocellular carcinoma: 2017-2024
Recent advances and issues in imaging modalities for hepatocellular carcinoma surveillance
Hepatocellular carcinoma in Korea: an analysis of the 2016-2018 Korean Nationwide Cancer Registry
Epidemiology and genomic features of biliary tract cancer and its unique features in Korea
Downstaging with atezolizumab-bevacizumab: a case series
Local ablation for hepatocellular carcinoma: 2024 expert consensus-based practical recommendation of the Korean Liver Cancer Association
Evolving trends in treatment patterns for hepatocellular carcinoma in Korea from 2008 to 2022: a nationwide population-based study
Practical consensus multi-specialty guidelines on image-guided ablation for hepatocellular carcinoma
Complications of immunotherapy in advanced hepatocellular carcinoma
Multidisciplinary approach for hepatocellular carcinoma patients: current evidence and future perspectives
Changing etiology and epidemiology of hepatocellular carcinoma: Asia and worldwide
Transarterial chemoembolization for hepatocellular carcinoma: 2023 expert consensus-based practical recommendations of the Korean Liver Cancer Association
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Diagnostic performance of the 2022 KLCA-NCC criteria for hepatocellular carcinoma on magnetic resonance imaging with extracellular contrast and hepatobiliary agents: comparison with the 2018 KLCA-NCC criteria
Effect of direct-acting antivirals for hepatitis C virus-related hepatocellular carcinoma recurrence and death after curative treatment
EUVIMED